Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10988537 Antibodies comprising chimeric constant domains

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 12, 2018
Date of Patent
April 27, 2021
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent Application Number
16128907
Patent Citations
‌
US Patent 10179819 Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
‌
US Patent 10772972 Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
‌
US Patent 10106610 Antibodies comprising chimeric constant domains
‌
US Patent 10738130 Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
Patent Citations Received
‌
US Patent 11590223 Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies
‌
US Patent 11518807 Heavy chain constant regions with reduced binding to Fc gamma receptors
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10988537
Patent Primary Examiner
‌
Sean E Aeder

Find more entities like US Patent 10988537 Antibodies comprising chimeric constant domains

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo